covid-19 vaccine

FDA delays decision on Moderna COVID-19 vaccine for kids 12-17

Reading now: 175
www.fox29.com

CAMBRIDGE, Mass. - A decision on the authorization of Moderna’s COVID-19 vaccine for kids ages 12 to 17 has been delayed while U.S.

regulators continue to study the rare risk of heart inflammation, the company said Sunday. The U.S. Food and Drug Administration told Moderna on Friday evening that its review could last until January, according to a company statement.

Moderna also said it will delay filing a request for emergency-use authorization of a lower dose of the vaccine for 6- to 11-year-olds."The safety of vaccine recipients is of paramount importance to Moderna," the company said in the statement.

Read more on fox29.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA